Next, to assess the association between ATP1A1/BCL2L1high and clinical features other than the maturation state, we stratified AML patients of different AML cohorts according to their ATP1A1/BCL2L1 median expression. The gene discussed is BCL2L1; the disease is acute myeloid leukemia.